期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Convenient one-pot synthesis of functionalized (E)-2-arylvinyl bromides from (E)-4-(2-bromovinyl)phenyl acetate
1
作者 Yu Bo Jiang Chun Xiang Kuang 《Chinese Chemical Letters》 SCIE CAS CSCD 2009年第5期545-548,共4页
A convenient one-pot synthesis of functionalized (E)-2-arylvinyl bromides was achieved by microwave-induced deacetylation and subsequent acylation using dicyclohexyl carbodiimide (DCC) and dimethylamino-pyridine ... A convenient one-pot synthesis of functionalized (E)-2-arylvinyl bromides was achieved by microwave-induced deacetylation and subsequent acylation using dicyclohexyl carbodiimide (DCC) and dimethylamino-pyridine (DMAP) at room temperature from (E)-4-(2-bromovinyl)phenyl acetate. 展开更多
关键词 One-pot synthesis (E)-2-Arylvinyl bromide ACYLATION deacetylATION
下载PDF
Construction of acetyl-CoA and DBAT hybrid metabolic pathway for acetylation of 10-deacetylbaccatin Ⅲ to baccatin Ⅲ 被引量:1
2
作者 Hao Wang Bo-Yong Zhang +4 位作者 Ting Gong Tian-Jiao Chen Jing-Jing Chen Jin-Ling Yang Ping Zhu 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2021年第10期3322-3334,共13页
10-DeacetylbaccatinⅢ(10-DAB)C10 acetylation is an indispensable procedure for Taxol semi-synthesis,which often requires harsh conditions.10-DeacetylbaccatinⅢ-10-β-O-acetyltransferase(DBAT)catalyzes the acetylation ... 10-DeacetylbaccatinⅢ(10-DAB)C10 acetylation is an indispensable procedure for Taxol semi-synthesis,which often requires harsh conditions.10-DeacetylbaccatinⅢ-10-β-O-acetyltransferase(DBAT)catalyzes the acetylation but acetyl-CoA supply remains a key limiting factor.Here we refactored the innate biosynthetic pathway of acetyl-CoA in Escherichia coli and obtained a chassis with acetyl-CoA productivity over three times higher than that of the host cell.Then,we constructed a microbial cell factory by introducing DBAT gene into this chassis for efficiently converting 10-DAB into baccatinⅢ.We found that baccatinⅢcould be efficiently deacetylated into 10-DAB by DBAT with CoASH and K+under alkaline condition.Thus,we fed acetic acid to the engineered strain both for serving as a substrate of acetyl-CoA biosynthesis and for alleviating the deacetylation of baccatinⅢ.The fermentation conditions were optimized and the baccatinⅢtiters reached 2,3 and 4.6 g/L,respectively,in a 3-L bioreactor culture when 2,3 and 6 g/L of 10-DAB were supplied.Our study provides an environmentfriendly approach for the large scale 10-DAB acetylation without addition of acetyl-CoA in the industrial Taxol semi-synthesis.The finding of DBAT deacetylase activity may broaden its application in the structural modification of pharmaceutically important lead compounds. 展开更多
关键词 Microbial cell factory Biosynthetic pathway of acetyl-CoA Bioconversion of 10-deacetylbaccatinⅢto baccatinⅢ 10-deacetylbaccatinⅢ-10-β-Oacetyltransferase deacetylation of baccatinⅢ High-cell-density fermentation Taxol semi-synthesis
原文传递
新骨架小分子南强菌素对紫杉醇耐药性的逆转作用及其机制
3
作者 张成梅 武传涛 +3 位作者 朱珊珊 贾舒 王一 史艳秋 《山东大学学报(医学版)》 CAS 北大核心 2013年第4期21-25,共5页
目的研究南强菌素(DM)对肿瘤细胞紫杉醇耐药性的逆转作用并探讨其逆转机制。方法 MTT法检测南强菌素对A549/T耐药细胞与A549敏感细胞的毒性及其对紫杉醇敏感性的影响,以Annexin V法检测细胞凋亡率和Rh123在耐药细胞中的积累,HPLC测定细... 目的研究南强菌素(DM)对肿瘤细胞紫杉醇耐药性的逆转作用并探讨其逆转机制。方法 MTT法检测南强菌素对A549/T耐药细胞与A549敏感细胞的毒性及其对紫杉醇敏感性的影响,以Annexin V法检测细胞凋亡率和Rh123在耐药细胞中的积累,HPLC测定细胞内紫杉醇的蓄积量,Western blotting检测Ⅲ型β微管蛋白的表达水平。结果南强菌素可显著提高A549/T细胞对紫杉醇的敏感性,增加紫杉醇诱导耐药细胞凋亡率,增强A549/T细胞中紫杉醇和Rh123的蓄积能力,同时,亦可明显抑制A549/T细胞中Ⅲ型β微管蛋白的表达水平。结论南强菌素可有效提高耐药细胞对紫杉醇的敏感性,逆转A549/T细胞对紫杉醇的耐药作用,其逆转机制可能与南强菌素抑制耐药肿瘤细胞膜上耐药蛋白P-糖蛋白的外泵转运功能和干扰Ⅲ型β微管蛋白的表达水平有关。 展开更多
关键词 南强菌素 紫杉醇 肿瘤细胞 多药耐药性 A549
原文传递
南强菌素在大鼠体内的药动学、组织分布及排泄研究
4
作者 朱珊珊 张成梅 +3 位作者 武传涛 贾舒 王一 史艳秋 《中国新药与临床杂志》 CAS CSCD 北大核心 2014年第6期464-468,共5页
目的研究海洋新骨架小分子南强菌素经单次静脉注射后在Wistar大鼠体内的药动学、组织分布及排泄特征。方法48只Wistar大鼠(雌雄各半)分为8组(每组雌雄各三只),3组分别尾静脉注射南强菌素10、20、30mg·kg^-1,液相色谱-串联质... 目的研究海洋新骨架小分子南强菌素经单次静脉注射后在Wistar大鼠体内的药动学、组织分布及排泄特征。方法48只Wistar大鼠(雌雄各半)分为8组(每组雌雄各三只),3组分别尾静脉注射南强菌素10、20、30mg·kg^-1,液相色谱-串联质谱法(LC—MS/MS)测定其血药浓度,DAS2.0计算药动学参数;其余5组单次尾静脉给予南强菌素20mg·kg^-1,其中3组大鼠给药后0.5、2、3h麻醉处死、解剖测定南强菌素组织分布,1组给药后收集0—2h、〉2—4h、〉4~8h、〉8~24h的尿液粪便评价南强菌素的排泄过程,1组麻醉后插管收取0~2h、〉2~16h、〉16~24h胆汁评价胆汁排泄。结果大鼠分别静脉单次注射10、20、30mg·kg。南强菌素后,t1/2 2分别为(2.09±0.68)、(2.44±0.35)、(2.57±1.33)h,AUCo-8h分别为(3378±544)、(3492±460)、(4451±573)μg·h·L^-1;单次静脉给药20mg·kg^-1,0.5h后肾脏组织中的南强菌素含量最高(1736.8ng·^g-1),肺脏及脾脏次之;给药2h后,多数组织中已经检测不到或仅能检测到极少量南强菌素;原型药物经尿样和胆汁的排泄率分别为1.87%和0.91%,粪便的排泄率极低,低于总给药量的0.01%。结论单次给予南强菌素,各剂量组的AUC0-8h、ρmax和t1/2 2.用SPSS进行相关检验,无显著差异(P〉0.05),表明在置信度(单双侧)0.05水平上剂量与AUC0-8h、和t1/22均不相关;原型药物经粪便和尿样排泄率较低,1~24h内仅有1.87%从尿液中排出。 展开更多
关键词 南强菌素 药动学 组织分布 排泄 色谱法 高压液相 串联质谱法
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部